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INTRODUCTION  
 
Majority of Upper limbs surgeries are done under nerve blocks.  In the last 
decade image guided peripheral nerve block have become the norm for the 
anesthesiologist at the forefront of regional anaesthesia. Out of that dominant 
method of imaging is ultrasonography. Ultrasound can determine the size, 
depth, and exact location of the brachial plexus and its neighboring structures. 
Real-time ultrasound imaging can help to guide the block needle to reach 
target nerves with fewer attempts. Under visual guidance, needle movement is 
purposeful and based on constant image feedback, thus avoiding nerve 
localization by trial and error. Various adjuvants were used as adjuvant for 
supraclavicular block, but many of them leads to side effects, here we used 
verapamil calcium channel blocker as adjuvant. Calcium plays an important 
role in pain formation. Verapamil (calcium channel blocker) has been shown to 
have potent local anesthetic activity, reflecting inhibition of fast sodium 
channels. It induces fast channel blocking effects similar to local anesthetics. 
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CLINICAL ANATOMY 
BRAXHIAL PLEXUS: 
The brachial plexus formed by anterior primary rami of cervical (C5,C6,C7,C8) 
and 1st thoracic segment. The plexus consists of roots, trunks, divisions, cords 
and branches. Most commonly formed by C5 to T1. However, variations may 
occur where C4 to C8 is known as prefixed plexus and C6 to T2 known as 
post fixed plexus. C4 mainly contributes to prefixed plexus. T1 mainly 
contributes to post fixed plexus. It provides cutaneous and motor innervation 
of entire upper limb with few exceptions. Prefixed plexus is associated with 
cervical rib likewise in post fixed plexus anomalous origin of 1st rib. 
 
Fig no 1: Mixed fibers of roots of brachial plexus 
 
11 
 
 
 
Fig no: 2 Brachial plexus 
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ROOTS: 
  The Roots emerge from the intervertebral foramen. They pass 
behind the foramen transversarium of the corresponding cervical vertebrae 
with its contained vertebral vessels and then lie in the transverse process in 
the groove between the anterior and posterior tubercles. All the roots lie 
between the scalenus anterior and scalenus medius muscle. In the groove 
they lie in a fibrofatty sheath. The anterior part of the sheath arises from the 
anterior tubercle which covers the posterior part of Scalenus anterior muscle. 
The posterior part of the sheath arises from posterior tubercles covering the 
front of Scalenus medius muscle.  
 
Fig no. 3: Roots of Brachial plexus 
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The roots lie in the posterior triangle of neck. The roots lie above the 
second part of subclavian artery.  
The roots receive: 
1. Grey rami from cervical sympathetic chain 
2. C5 and C6 from middle cervical ganglion 
3. C7 and C8 from inferior cervical ganglion 
4. T1 from ganglion of T1. 
 
The branches arising from the Roots: 
1. Nerve to rhomboids (dorsal scapular nerve C5) 
2. Nerve to serratus anterior or long thoracic nerve or nerve of bell (C5-C7) 
3. Branches to longus colli (C5-C8) 
4. Branches to scaleni muscles (C5-C8) 
5. Branch to phrenic nerve (C4) 
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TRUNKS: 
 The upper trunk is formed by the union of C5 and C6 roots. 
The middle trunk is formed by C7 
The lower trunk is formed by the union of C8 and T1. 
They emerge as trunks from between the scalene group of muscles, crossing 
the posterior triangle goes across the first rib. In the posterior triangle of neck 
trunks lie deep to the floor of the triangle. Behind the clavicle at the lateral 
border of first rib, trunks divide into anterior and posterior division.  And it 
enters the axilla via cervico axillary canal where they join to form the cords. 
Fig no 4: Relations of Trunk 
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Trunks invested in prevertebral fascia are superficial and covered only by skin, 
platysma and deep fascia. However, crossed by – the inferior belly of 
omohyoid, the external jugular vein, the transverse cervical artery and the 
supraclavicular nerves. The upper and middle trunk lies above the subclavian 
artery. The lower trunk lies behind the artery. 
 
Branches Arising from Trunks 
1. The branches arising from the trunks of the brachial plexus are: 
            a. Nerve to the subclavius  
            b. Suprascapular nerve. 
2. The nerve to the subclavius descends in front of the brachial plexus and 
in front of third part of the subclavian artery. It passes behind the clavicle to 
reach the deep surface of the subclavius that it supplies. 
3. The suprascapular nerve runs laterally and backwards over the shoulder. 
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CORDS: 
The cords are named according to their relationship to axillary artery.  
1. Lateral cord 
2. Medial cord 
3. Posterior cord 
Lateral cord- anterior divisions of upper and middle trunk unite to form the 
lateral cord. It lies lateral to the first and second part of axillary artery before 
giving branches.  
a) lateral pectoral nerve (C5–7) 
b) musculocutaneous nerve (C5–7) 
c) lateral root of median nerve (C6, C7). 
 
Fig no.5 Relation to Axillary artery 
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Medial cord: 
The anterior division of lower trunk forms the medial cord. It lies posterior to 
the first part of axillary artery with its medial pectoral branch. It lies medial to 
the second part of axillary artery.  
 
Fig no 6: Medial cord 
Branches:  
a) Medial pectoral nerve (C8, T1) 
b) Medial cutaneous nerve of arm (C8, T1) 
c) Medial cutaneous nerve of forearm (C8, T1) 
d) Medial head of median nerve (C8, T1) 
e) Ulnar nerve (C7–8, T1) 
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POSTERIOR CORD: 
Posterior division of all the three trunks unite to form the posterior cord. It lies 
lateral to the first part of axillary artery and posterior to the second part.  
Branches: 
a) Upper subscapular nerve (C5, C6) 
b) Nerve to latissimus dorsi (thoracodorsal nerve) (C6–8) 
c) Lower subscapular nerve (C5, C6) 
d) Axillary nerve (C5, C6) 
e) Radial nerve (C5–8, T1). 
 
      
Fig no 7: Posterior cord 
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ULTRASONOGRAM 
Ultrasound allows noninvasive visualization of tissue structures. Ultrasound 
sound guided nerve block have become very popular and it is essential in 
regional anaesthesia. In 1880, French physicists Pierre Curie and Paul-
Jacques Curie, discovered the piezoelectric effect, which can generate and 
receive mechanical vibrations with high frequency. In 1978 P.La Grange and 
his colleagues published a case series report of ultrasound application for 
peripheral nerve block. In 61 patients they performed Supraclavicular brachial 
plexus block for which they used doppler transducer to locate the subclavian 
artery.  In 1989 Ting and Sivagnarathnam used B mode ultrasound and 
demonstrated anatomy of axilla and axillary brachial plexus block drug spread.  
 
Ultrasound is high-frequency sound and refers to mechanical vibrations above 
20 kHz. Ultrasound frequencies commonly used for medical diagnosis are 
between 2 and 15 MHz 
 
The piezoelectric effect is an effect exhibited by the generation of an electric 
charge in response to mechanical force applied on certain materials. 
Mechanical deformation can be produced when an electric field is applied to 
such material, also called the piezoelectric effect. 
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Quartz crystals, ceramic materials and Lead zirconate titanate are materials 
that exhibit piezoelectric effect. Lead free piezoelectric materials are under 
development. 
 
Fig no 8: piezoelectric effect 
 
While passing through the tissue’s ultrasound wave comes across various 
interactions like reflection, scattering and absorption. 
Where there is a boundary between different media part of ultrasound is 
reflected and the rest is transmitted. The reflection intensity is solely 
dependent on the angle which means the transducer should be placed 
perpendicular to the target nerve for clear visualization.  
The coupling medium is necessary to displace the air from the transducer and 
air interface. Gels and oils are used for this purpose they act as lubricants 
providing a smooth surface scanning. 
Scattering is redirection of ultrasound waves by rough surface or 
heterogeneous media.  
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B MODE: 
The primary mode used in regional anesthesia. It provides cross sectional 
image for the area of interest. In this, there is simultaneous scanning from a 
linear array of 100-300 piezoelectric crystals. The amplitude of the echo is 
converted into dots of different brightness in B scan. The echo strength is 
indicated by the gray scale intensity and real distance in tissues is represented 
by horizontal and vertical distances. 
 
Fig no 9: B mode transducer 
 
DOPPLER MODE- to detect the presence and nature of blood vessels.  
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In regional anaesthesia two types of transducers are used- Linear and 
curvilinear transducers.  
Linear Curvilinear 
Rectangular Curvilinear in shape  
Beam is rectangular, and the near-field 
resolution 
Convex beam and in-depth 
examinations 
2 to 16 MHz 2 to 7 MHz 
Table 1- linear and curvilinear probe 
 
Fig no 10: Transducer 
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The peripheral nerves are in close vicinity to the vessels or between the 
muscle layers in general. The echo texture can be hyperechoic, hypoechoic or 
honeycomb pattern. To facilitate adequate nerve imaging, proper selection of 
sonographic modes, functional keys adjustment, needle visualization and 
image artifact interpretation are the certain steps. For peripheral nerve 
visualization three imaging modes are commonly used- conventional imaging, 
compound imaging and tissue harmonic imaging (THI). 
For achieving an optimal image while performing peripheral nerve imaging five 
functional keys on an ultrasound machine play vital role 
1) Depth 2) Frequency 3) Focusing 4) Gain 5) Doppler 
 
Fig no 11: Compound and Conventional Imaging 
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With the relevance to needle -transducer relationship, two needle insertion 
techniques are being used commonly.  
In-plane technique: Needle is placed in the plane of ultrasound beam. Hence 
the needle shaft and tip can be observed in the longitudinal view when it is 
advanced towards the target structure. One should stop advancing the needle 
when the needle visualization fails. Tilting or rotating the transducer can help 
with visualization. 
Out of plane technique: The needle is inserted perpendicular to the 
transducer. The shaft of the needle is seen in the cross-sectional plane and as 
a bright dot. 
 
Fig no 12: In-plane and out of plane technique 
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Fig no 13: Operational setup 
FIELD DEPTH 
(CMS) 
FREQUENCY 
(MHZ) 
PERIPHERAL BLOCKADES 
< 2 12-15 Wrist, ankle block 
2-3 10-12 Interscalene and axillary 
3-4 10-12 Femoral, Supraclavicular and TAP 
4-7 5-10 Infraclavicular, Popliteal and sub gluteal 
sciatic nerve block 
7-10 5-10 Pudendal, gluteal sciatic and lumbar plexus 
block 
>10 3-5 Anterior approach to sciatic nerve 
 
Table no 2: Imaging depth and frequency for common peripheral nerve blocks 
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ULTRASOUND ARTIFACTS: 
Ultrasound artifact is any image aberration that does not represent the correct 
anatomic structures. Most artifacts are undesirable, and operators must learn 
how to recognize them during nerve blockade. 
 
Fig no 14: Artifacts 
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                                                    LIGNOCAINE 
❖ Lignocaine an aminoethyl amide an amide group local anaesthetic. 
 
❖ Introduced in 1948 
❖ Most widely used local anaesthetic and also an antiarrhythmic agent. 
❖ Lidocaine produces faster, more intense, longer-lasting, and more 
extensive anesthesia than does an equal concentration of procaine. 
❖ It blocks the nerve conduction by decreasing the entry of sodium ions 
during the upstroke of action potential. 
❖ Once the concentration of local anesthetics increases the rate of rise of 
action potential and the maximum depolarization decreases causing 
slowing of conduction. Hence local depolarization doesn’t reach the 
threshold potential and conduction block ensues. 
❖ Lidocaine is absorbed rapidly after parenteral administration and from 
the GI and respiratory tracts. 
❖ Lidocaine is dealkylated in the liver by CYPs to monoethylglycine 
xylidide and glycine xylidide, which can be metabolized further to 
monoethylglycine and xylidide. 
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❖ Both monoethylglycine xylidide and glycine xylidide retain local 
anesthetic activity. 
❖ About 75% of the xylidide is excreted in the urine as the further 
metabolite 4-hydroxy-2,6-dimethylaniline. 
❖ Duration of action after infiltration- 60-120 minutes 
❖ Maximum single dose for infiltration – 300mg 
❖ pKa- 7.9 
❖ Protein binding – 70% 
❖ Nonionized fraction at pH 7.4- 25% 
❖ Nonionized fraction at pH 7.6- 33% 
❖ Lipid solubility- 2.9, Volume of distribution- 91 liters (L) 
❖ Clearance – 0.95 L/min. 
❖ Elimination half time – 96 minutes 
 
Table no 3: Effects of lignocaine 
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BUPIVACAINE 
❖ Bupivacaine is a widely used amide local anesthetic. 
❖ Similar to that of lidocaine except that the amine-containing group is a   
    butyl piperidine. 
❖ Potent anaesthesia producing long lasting effect. 
 
❖ First synthesized in 1957 by Ekenstam 
❖ More sensory than motor blockade has made it popular drug for 
prolonged postoperative pain and labour analgesia. 
❖ Recently liposomal derived bupivacaine was approved by FDA 
❖ More slowly absorbed than lignocaine. 
❖ Bupivacaine is primarily metabolized in the liver by CYP3A4 to 
pipecolylxylidine, which is then glucuronidated and excreted. 
❖ Alpha 1 acid glycoprotein important plasma protein site of bupivacaine.   
❖ Duration of action after infiltration- 240-480 minutes 
❖ Maximum single dose for infiltration – 175mg 
❖ pKa- 8.1 
❖ Protein binding – 95% 
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❖ Nonionized fraction at pH 7.4- 17% 
❖ Nonionized fraction at pH 7.6- 24% 
❖ Lipid solubility- 28 
❖ Volume of distribution- 73 liters (L) 
❖ Clearance – 0.47 L/min. 
❖ Elimination half time – 210 minutes 
❖ IV injection of bupivacaine result in precipitous hypotension, cardiac 
dysrhythmias, and atrioventricular heart block. 
❖ QT prolongation, ventricular tachycardia most common side effect. 
❖ Cardio toxic dose occurs at plasma concentration 8-10 mcg/ml  
❖ Cardio toxicity sensitivity is more in pregnancy 
❖ Drowsiness occurs at plasma concentration 1.5 mcg/ml 
❖ Peripheral paresthesia occurs at plasma concentration 2 mcg/ml 
❖ Convulsions occur at plasma concentration 4 mcg/ml. 
❖ Available hyperbaric forms include concentrations of 0.5% and 0.75%, 
with dextrose 8.25%. 
❖ Isobaric formulations are available in concentrations of 0.5% and 0.75%.  
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                                                  VERAPAMIL  
 
❖ Developed in 1962 in Germany. 
❖ Initially developed as coronary dilator and also have a cardio depressant 
property. 
 
❖ Phenylalkylamine type of calcium channel blocker.  
❖ L-Verapamil is the more potent Ca2+ channel blocker. 
❖ In the neurons they block the neurotransmitter release.  
❖ It has some alpha-adrenergic blocking activity also.  
❖ It inhibits the transmembrane influx of extracellular calcium ions into 
myocardial and vascular smooth muscle cells, causing dilatation of the 
main coronary and systemic arteries and thereby decreasing myocardial 
contractility. 
❖ Selective inhibition of calcium influx through cellular membranes. 
❖ Class 4 antiarrhythmic agent  
❖ Bioavailability: 20-35% 
❖ Onset: IV, 1-5 minutes 
❖ Duration: IV, 10-20 min; PO, 6-8 hour 
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❖ Peak plasma time: 1-2 hour 
❖ Protein bound 94% 
❖ Volume of distribution- 3.8 L/kg 
❖ Metabolized by hepatic P450 enzyme CYP3A4 
❖ Metabolites: Norverapamil (active) 
❖ Half-life: Infants, 4.4-6.9 hour; single dose, 3-7 hour; multiple doses, 4.5 
hour; severe hepatic impairment, 14-16 hour 
❖ Clearance: 0.5-1 L/hour/kg 
❖ Excretion: Urine (70%), feces (9-16%) 
❖ Nausea, constipation and bradycardia are common than other calcium 
channel blockers. 
❖ Flushing, ankle edema and headache are less common. 
❖ Should not be given with beta blockers. 
ANTINOCICEPTION: 
• Verapamil induces fast sodium channel blocking effects similar to 
local anaesthetics 
• It inhibits calcium influx thereby reducing intracellular calcium, which 
plays an important role in potentiation of spinal cord and in pain 
formation (activation of NMDA receptors). 
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SUPRACLAVICULAR BLOCK 
Ultrasound guided peripheral nerve blocks were first described in the 
supraclavicular region. In this region the brachial plexus is compact the 
visibility of the nerve is extremely good and the structures are shallow (20-
30mm). The brachial plexus divisions are seen in sonography. Supraclavicular 
block of brachial plexus provides anaesthesia for upper arm, forearm and 
hand. Ultrasound-guided supraclavicular block is more reliable for anesthesia 
of the radial nerve than is ultrasound guided infraclavicular block. Because the 
inferior trunk is away from the block needle and may behind the subclavian 
artery, the supraclavicular approach may rarely fail to provide adequate 
anesthesia in the ulnar nerve. Even in obese patients, the supraclavicular 
block can be performed with high success and low complication rates. 
 
Fig no: 15 Supraclavicular brachial plexus 
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Supraclavicular block is often called the “spinal anesthesia of the upper 
extremity”.  
 
Fig no 16: Sensory Distribution of Upper limb 
 
ULTRASOUND ANATOMY: 
 
FIG NO:17 Anatomy of the supraclavicular brachial plexus with proper 
transducer placement 
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The subclavian artery crosses the first rib between the insertions of 
anterior and middle scalene muscles, posterior to midpoint of the 
clavicle. The subclavian artery is seen as an anechoic round structure. 
The parietal pleura and first rib can be seen as a linear hyperechoic 
structure lateral and deep to the subclavian artery. The rib casts an 
acoustic shadow so that the image field deep to rib appears anechoic. 
The brachial plexus seen as bundle of hypoechoic round nodules just 
posterior and superficial to the subclavian artery. It is possible to see the 
fascial sheath of the muscles surrounding the brachial plexus. 
 
 
Fig no 18: US anatomy of Brachial plexus 
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 Adjusting the transducer, the upper, middle and lower trunks of the 
brachial plexus can be individually identified, as they join together at 
costoclavicular space. To visualize the lower trunk the transducer is 
oriented in sagittal plane, until the rib is seen deep to plexus and 
subclavian artery. Anterior or posterior to the rib is hyperechoic pleura 
with lung tissues deep to it.  The brachial plexus is typically seen 1 to 2 
cm deep at this location. 
 
Fig no 19: Ultrasound images of the brachial plexus 
Sagittal view and Oblique view 
The dorsal scapular artery commonly passes through or within the brachial 
plexus. It is important to recognize that the superficial and lateral branches 
come from C5–C7 (shoulder, lateral aspect of arm, and forearm) can be traced 
up to the interscalene area, whereas the deeper and medial contingent are 
branches of C8 and T1 (hand and medial aspect of forearm). 
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 Adequate spread of local anesthetic in both areas is necessary for successful 
block of the arm and hand. 
 
EQUIPMENT: 
• Ultrasound machine with linear transducer (8–18 MHz), sterile sleeve, 
and gel  
• Standard nerve block tray 
• Local anesthetic 
• 5-cm, 22-gauge, short-bevel, insulated stimulating needle 
• Peripheral nerve stimulator 
• Sterile gloves 
LANDMARK AND POSITIONING: 
Performed with the patient in the supine, semi-sitting, or slight lateral 
position, with the patient’s head turned away from the side to be 
blocked. When possible, asking the patient to reach for the ipsilateral 
knee will depress the clavicle slightly and allow better access to the 
structures of the anterolateral neck. 
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GOAL: 
The goal of this block is to place the needle within the plexus sheath 
posterior to the subclavian artery and inject local anesthetic to surround 
the trunks and divisions of the plexus. 
TECHNIQUE: 
 
Fig no 20: Transducer placement 
With the patient in the proper position, the skin is disinfected and the 
transducer is positioned in the transverse plane immediately superior to the 
clavicle at approximately its midpoint. The transducer is tilted caudally to 
obtain a cross-sectional view of the subclavian artery. The brachial plexus is 
seen as a collection of hypoechoic oval structures lateral and superficial to the 
artery. Using a 25- to 27-gauge needle, 1 to 2 mL of local anesthetic is injected 
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into the skin 1 cm lateral to the transducer to decrease the discomfort during 
needle insertion.  
Observe the distribution of the local anesthetic during administration by 
injecting small amounts of the local anesthetic as the needle advances 
through tissue layers.  
 
Fig no 21: Supraclavicular brachial plexus- Needle path 
The block needle is then inserted in-plane toward the brachial plexus, in a 
lateral-to-medial direction. After a careful aspiration, 1 to 2 mL of local 
anesthetic is injected to document the proper needle placement. When the 
injection displaces the brachial plexus away from the needle, an additional 
advancement of the needle 1 to 2 mm deeper may be required to accomplish 
adequate spread of the local anesthetic.  
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 To achieve the best possible view, the transducer must be tilted slightly 
inferiorly, rather than perpendicular to the skin. The goal is to see the artery as 
a pulsating circular structure, rather than an oval or linear structure. 
 
Fig no 22: Desired area of spread (blue shaded) 
❖ A motor response to nerve stimulation is not necessary if the plexus, 
needle, and local anesthetic spread are well visualized. 
❖ The neck is a highly vascular area, and care must be taken to avoid 
needle placement or injection into the vascular structures. Of particular 
importance is subclavian artery and dorsal scapular artery. 
❖ Pneumothorax is also a rare but possible complication. 
❖ Phrenic nerve paresis is also reported in up to 30% of patients. 
❖ Never inject drug against resistance. 
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REVIEW OF LITERATURE 
1. The study conducted by Sidharth Sraban Routray, Debasis 
Mishra, Daityari Routray, and Kasturi Nanda to study the effects of 
verapamil as adjuvant to levobupivacaine in supraclavicular block for 
upper extremity surgery. In this double-blinded clinical trial, 60 American 
Society of Anesthesiologist Class I and II patients posted to undergo 
upper extremity surgery were divided into 2 different groups randomly. In 
Group A, the patients received 30 ml levobupivacaine 0.5% plus 2 ml 
normal saline and Group B patients received 30 ml levobupivacaine 
0.5% plus 5 mg verapamil diluted to 2 ml normal saline for 
supraclavicular block. Time of request for rescue analgesia, onset and 
duration of sensory motor blocks and changes in hemodynamic 
parameters were studied and analyzed. P < 0.001 was considered 
statistically significant. Time for a request for rescue analgesia was 
425.80 ± 90.46 min in Group B and 366.13 ± 70.42 min in Group A 
which was clinically significant. The mean of sensory and motor block 
onset time in Group B was less than in Group A, the difference between 
the two groups being statistically significant (P < 0.001). In Group A, 
mean duration of sensory block was 316.13 ± 91.08 min and in Group B 
was 375.83 ± 114.48 min, which was statistically significant (P < 0.001). 
The addition of verapamil as an adjuvant to levobupivacaine in brachial 
plexus blockade delayed the requirement of rescue analgesia with 
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decreased onset time and prolonged duration of sensory and motor 
block characteristics.  
2. The study titled Verapamil as an Adjunct to Local Anaesthetic for 
Brachial Plexus Blocks conducted by Gp Capt RK Lalla, Gp Capt S 
Anant (Retd), Air Cmde HS Nanda. Calcium channel blockers 
potentiate the effects of local anaesthetics. We examined the effect of 
adding verapamil to local anaesthetic solution on anaesthetic duration in 
patients undergoing surgery under brachial plexus block. This study was 
a prospective, randomized, controlled, double blind study. Sixty patients 
undergoing elective upper limb surgery were divided into two groups of 
30 each. Group A received 40 ml of 1% lignocaine with 0.25% 
bupivacaine, while Group B patients had 2.5 mg verapamil added. Onset 
of sensory blockade time was marginally faster in Group B (23.2 ± 3.94 
minutes) as compared to Group A (23.9 ± 4.13 minutes). However, this 
difference was statistically not significant. The increase in duration of 
sensory blockade in Group B (185 ± 46.52 minutes) as compared to 
Group A (157 ± 44.28 minutes) was statistically significant (p= 0.011). 
Increase in duration of motor blockade in Group B (161 ± 46.14 minutes) 
as compared to Group A (149 ± 42,76 minutes) was statistically not 
significant (p = 0.15). Similarly, prolongation of analgesic duration in 
Group B (318 ± 69.54minutes) as compared to Group A (302 ± 0.69 
minutes) was statistically not significant (p=0.18). We conclude that 
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adding verapamil to brachial plexus block can prolong sensory 
anaesthesia without any effect on analgesic duration. 
3. The study titled the effect of verapamil as an adjuvant agent with local 
anesthetic on sensory block level, hemodynamic and postoperative pain 
conducted by Tabaeizavareh MH, Omranifard M, Moalemi A. In this 
prospective randomized interventional clinical double-blind study ASA 
physical status, I or II male patients referred for elective lower abdominal 
surgery were enrolled. They randomized in group A (20cc of 0.5% 
bupivacaine plus 5 mg verapamil) and B (20cc of 0.5% bupivacaine plus 
2cc normal saline). The sensory level block, postoperative pain, opioid 
consumption and vomiting and nausea and hemodynamic state was 
recorded and compared in two groups. Sixty-two patients were studied. 
Mean of the sensory level block 20 minutes after stating epidural 
anesthesia and immediately after surgery, postoperative pain score, 
opioid consumption and nausea and vomiting and fluid intake was not 
significantly different in two groups (P>0.05). Mean of systolic and 
diastolic blood pressure and pulse rate changes was not significantly 
different in two groups (P>0.05). Verapamil as an adjuvant with 
bupivacaine could not significantly increase the level of sensory block 
and attenuate post-operative pain and analgesic consumption and 
hemodynamic condition of the patients. For more accurate results it is 
recommended to determine the effect of different dose of verapamil in 
45 
 
larger sample size of the patients. Studying the effect of other Ca 
channel blockers would be favorable in this regard. 
4. The study titled Brachial plexus anesthesia with verapamil and/or 
morphine conducted by Reuben SS, Reuben JP. Calcium channel 
blockers potentiate the analgesic properties of both local anesthetics 
and opioids. We examined the analgesic effects of administering 
morphine, verapamil, or its combination into the brachial plexus sheath 
with lidocaine in 75 patients undergoing upper extremity orthopedic 
surgery. All patients received brachial plexus anesthesia with 40 mL of 
1.5% lidocaine and epinephrine 5 microg/mL. In addition, patients were 
randomized to 1 of 5 groups: Group 1 received IV saline; Group 2 
received IV verapamil 2.5 mg and morphine 5 mg; Group 3 received IV 
verapamil 2.5 mg and morphine 5 mg was added to the lidocaine 
solution; Group 4 received IV morphine 5 mg and verapamil 2.5 mg was 
added to the lidocaine solution; and Group 5 received verapamil 2.5 mg 
and morphine 5 mg were added to the lidocaine solution. 
Postoperatively, patients rated their pain (0-10) at 1, 6, 12, and 24 h. 
Patients were instructed to take 1 acetaminophen 325 mg/oxycodone 5 
mg tablet every 3 h whenever the pain score exceeded 3. Analgesic 
duration was significantly increased in those patients receiving brachial 
plexus blocks with morphine (Groups 3 and 5) (P < 0.005). The total 24 
h acetaminophen/oxycodone use was also less in Groups 3 and 5 (P < 
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0. 03). Duration of anesthesia (time of abolition of pinprick response) 
was significantly increased in those patients receiving brachial plexus 
blocks with verapamil (Groups 4 and 5) (P = 0.002). We conclude that 
the addition of verapamil to brachial plexus block with lidocaine can 
prolong the duration of sensory anesthesia, but it had no effect on 
analgesic duration of 24 h analgesic use. 
5. The study titled Evaluation of the analgesic effect of 2 doses of 
verapamil with bupivacaine compared with bupivacaine alone in 
supraclavicular brachial plexus block conducted by Mosaffa F, Salimi A, 
Lahiji F, Kazemi M, Mirkheshti. In this double blinded clinical trial, we 
divided 60 ASA class I and II patients who were to undergo upper 
extremity surgery (aged between 18-40 yrs) into 3 different groups 
randomly. In group I the patients received 30ml Bupivacaine 0.5% plus 
2ml normal saline for injection. Group II included patients who received 
30ml bupivacaine 0.5% plus 2.5mg verapamil locally and 1ml normal 
saline for injection. In group III the patients got 30ml bupivacaine 0.5% 
plus 5mg of local verapamil. All blocks were performed through a 
supraclavicular brachial plexus procedure, and time of initiating sensory 
and motor blocks and onset of complete anesthesia and also blood 
pressure alterations and heart rates were studied and taken into 
consideration. For data analysis we used SPSS 11.5 software. Our 
results clarified that verapamil decreased the onset time of anesthesia, 
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motor block and total anesthesia but there was no statistical difference 
between 2.5 and 5mg doses of verapamil (P>0.05). Among patients who 
received verapamil in the block, variation of more than 20% from 
baseline wasn’t detected in blood pressure and heart rate. According to 
our findings, verapamil causes a decrease in onset times of sensory and 
motor block and the initiation of complete anesthesia of bupivacaine in 
supraclavicular block, but there were no significant differences between 
groups II (verapamil 2.5mg) and III (verapamil 5mg). Blood pressure and 
heart rate fluctuations were not more than 20% in group II and III. 
6. The study conducted by Miranda HF, Bustamante D, Kramer V, 
Pelissier T, Saavedra H, Paeile C, et al. Antinociceptive effects of 
Ca2+ channel blockers. The antinociceptive action of four Ca2+ channel 
blockers, nifedipine, nimodipine, verapamil and diltiazem, was evaluated 
and compared to that of morphine using three algesiometric tests in 
mice and rats, namely, formalin, writhing and modified hot-plate test. 
Dose-response curves for all the drugs tested were similar and a 
significant dose-dependent antinociceptive action was evident in the 
formalin and writhing tests. However, in the hot-plate test, only 
nimodipine exhibited a significant analgesic effect, confirming the 
misleading results previously reported for this test. The findings suggest 
a pharmacological role of Ca2+ channel blockers in the modulation of 
antinociception under acute conditions. The analgesic action of Ca2+ 
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channel blockers could be mediated by an increase in the nociceptive 
threshold resulting from interference with Ca2+ influx at opioid receptors, 
because Ca2+ influx is critical for the release of neurotransmitters and 
other substances implicated in nociception and inflammation. It is 
suggested that if a substance has a Ca2+ channel blocking effect, it 
should probably have some antinociceptive properties. 
7. The study titled Ultrasound-guided supraclavicular approach for regional 
anesthesia of the brachial plexus. prospectively studied 40 patients 
(ASA grades I-III) undergoing surgery of the forearm and hand, to 
investigate the use of ultrasonic cannula guidance for supraclavicular 
brachial plexus block and its effect on success rate and frequency of 
complications. Patients were randomized into Group S (supraclavicular 
paravascular approach; n = 20) and Group A (axillary approach; n = 20). 
Ultrasonographic study of the plexus sheath was done. After 
visualization of the anatomy, the plexus sheath was penetrated using a 
24-gauge cannula. Plexus block was performed using 30 mL 
bupivacaine 0.5%. Onset of sensory and motor block of the radial, ulnar, 
and median nerves was recorded in 10-min intervals for 1 h. Satisfactory 
surgical anesthesia was attained in 95% of both groups. In Group A, 
25% showed an incomplete sensory block of the musculocutaneous 
nerve, whereas all patients in Group S had a block of this nerve. 
Complete sensory block of the radial, median, and ulnar nerves was 
attained after an average of 40 min without a significant difference 
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between the two groups. Because of the direct ultrasonic view of the 
cervical pleura, we had no cases of pneumothorax. An accidental 
puncture of subclavian or axillary vessels, as well as neurologic damage, 
was avoided in all cases. An ultrasonography-guided approach for 
supraclavicular block combines the safety of axillary block with the larger 
extent of block of the supraclavicular approach. 
8. The study titled Ultrasound guidance speeds execution and improves 
the quality of supraclavicular block. In this prospective study, we 
assessed the quality, safety, and execution time of supraclavicular block 
of the brachial plexus using ultrasonic guidance and neurostimulation 
compared with a supraclavicular technique that used anatomical 
landmarks and neurostimulation. It was hypothesized that ultrasonic 
guidance would increase the proportion of successful blocks, decrease 
block execution time, and reduce the incidence of complications such as 
pneumothorax and neuropathy. Eighty patients were randomized into 
two groups of 40, Group US (supraclavicular block guided in real time by 
a two-dimensional ultrasonic image, with neurostimulator confirmation of 
correct needle position) and Group NS (supraclavicular block using the 
subclavian perivascular approach, also with neurostimulator 
confirmation). Blocks were performed using bupivacaine 0.5% and 
lidocaine 2% (1:1 vol) with epinephrine 1:200000 as the anesthetic 
mixture. The onset of motor and sensory block for the 
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musculocutaneous, median, radial, and ulnar nerves was evaluated over 
a 30 min period. At 30 min 95% of patients in Group US and 85% of 
patients in Group NS had a partial or complete sensory block of all nerve 
territories (P = 0.13) and 55% of patients in Group US and 65% of 
patients in Group NS had a complete block of all nerve territories (P = 
0.25). Surgical anesthesia without supplementation was achieved in 
85% of patients in Group US and 78% of patients in Group NS (P = 
0.28). No patient in Group US and 8% of patients in Group NS required 
general anesthesia (P = 0.12). The quality of ulnar block was 
significantly inferior to the quality of block in other nerve territories in 
Group NS, but not in Group US; the quality of ulnar block was not 
significantly different between Groups NS and US. The block was 
performed in an average of 9.8 min in Group NS and 5.0 min in Group 
US (P = 0.0001). No major complication occurred in either group. We 
conclude that ultrasound-guided neurostimulator-confirmed 
supraclavicular block is more rapidly performed and provides a more 
complete block than supraclavicular block using anatomic landmarks 
and neurostimulator confirmation. IMPLICATIONS: Ultrasound-guided 
neurostimulator-confirmed supraclavicular block is more rapidly 
performed and provides a block of better quality than supraclavicular 
block using anatomic landmarks and neurostimulator confirmation. 
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9. The study titled Antinociceptive effects of intrathecal L-type calcium 
channel blockers on visceral and somatic stimuli in the rat conducted by 
Hara K, Saito Y, Kirihara Y, Sakura S, Kosaka Y. L-type calcium 
channels can modulate neuronal transduction in the spinal cord. 
However, their role in noxious information processing in animals that are 
physiologically intact has not been elucidated. We evaluated the effects 
of L-type calcium channel blockers diltiazem and verapamil on somatic 
and visceral nociception at the level of the spinal cord. Intrathecal 
catheters were inserted at the L4-5 level in Sprague-Dawley rats. The 
tail flick (TF) test and colorectal distension (CD) test were used to 
assess somatic and visceral antinociceptive effects, respectively. Motor 
function was assessed by posture and muscle tone in the limbs. TF 
latency and CD threshold were measured before and for 180 min after 
the intrathecal administration of verapamil (50, 100, 300, and 500 
microg), diltiazem (100, 300, 500, and 1000 microg), or isotonic sodium 
chloride solution. The percent maximal possible effect (%MPE) was 
calculated by transforming response threshold in TF and CD tests. 
Intrathecally administered diltiazem or verapamil increased both TF 
latency and CD threshold in a dose-dependent fashion. Isotonic sodium 
chloride solution, diltiazem 100 microg, and verapamil 50 microg did not 
increase %MPE in either test. Diltiazem 300 or 500 microg or verapamil 
300 or 500 microg significantly (P < 0.05) increased %MPE, with the 
peak effects 5 min after administration and short-duration 
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antinociception. %MPE was 100% until 15 min after the administration of 
diltiazem 1000 microg, and significant antinociception continued until 
180 min in the TF test. Motor paralysis was observed after the 
administration of the larger dose of each drug. We demonstrated that 
intrathecally administered L-type calcium channel blockers diltiazem or 
verapamil produced both somatic and visceral antinociception and motor 
block dose-dependently. They examined the effects of intrathecally 
administered L-type calcium channel blockers diltiazem and verapamil 
on somatic and visceral nociception in rats. L-type calcium channel 
blockers produced antinociceptive effects, suggesting a possible clinical 
application to control pain. 
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10. The study conducted by Brose WG, Gutlove DP, Luther 
RR, Bowersox SS, McGuire D titled Use of intrathecal SNX-111, a 
novel, N-type, voltage-sensitive, calcium channel blocker, in the 
management of intractable brachial plexus avulsion pain. he objective 
was to assess the analgesic, antihyperesthesic, and anti-allodynic 
properties of SNX-111 in neuropathic pain. They described a patient with 
refractory, severe deafferentation pain successfully treated with SNX-
111 in an open-label, baseline-controlled Phase I/II trial. The patient was 
hospitalized for treatment and observation. The patient was a 43-year-
old man with intractable deafferentation pain of 23 years' duration 
secondary to brachial plexus avulsion. SNX-111, the first neuron-
specific, N-type, voltage-sensitive calcium channel blocker developed for 
clinical use, was administered by continuous, constant-rate, intrathecal 
infusion via an indwelling cervical catheter. he primary outcome 
measures were the Visual Analog Scales of Pain Intensity (VASPI) and 
Pain Relief (VASPR). The patient experienced complete pain relief 
(VASPI = 0.0 cm and VASPR = 10.0 cm) with elimination of 
hyperesthesia and allodynia. SNX-111, administered intrathecally by 
continuous, constant-rate infusion, produced dose-dependent pain relief 
in a 43-year-old male patient with a 23-year history of intractable 
deafferentation and phantom limb pain secondary to brachial plexus 
avulsion and subsequent amputation.  
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Dizziness, blurred vision, and lateral-gaze nystagmus were dose-
dependent side effects that resolved with decreasing dose levels. 
Complete pain relief was achieved in this patient without side effects 
after dose adjustment. We conclude that SNX-111 is a potent analgesic, 
antihyperesthesic, and antiallodynic agent. Controlled studies of SNX-
111 in patients with malignant and nonmalignant pain syndromes are 
warranted and are under way. 
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BACKGROUND 
  
Ultrasound guided supraclavicular block is used for upper limb surgeries 
and various additives were used to prolong the duration of blockade. 
Additives like opioids, alpha agonists, steroids have been used along 
with local anaesthetics to prolong its action and it has certain side effects 
too. I have added verapamil as an adjuvant to supraclavicular block. I 
have done this prospective study to the effect of adding verapamil to 
local anaesthetics. This study is to evaluate the hemodynamic changes, 
onset of sensory and motor blockade, duration of sensory and motor 
blockade, post op VAS, duration of analgesia, number of rescue 
analgesia needed and satisfaction score.  
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AIM OF THE STUDY 
 
• Primary aim of this study is to find out the need of rescue analgesia in 
first 24 hours and number of rescue analgesia required in first 24 hours. 
 
• Effect of sensory and motor characteristics like onset and duration were 
secondary aim. 
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MATERIALS AND METHODS 
➢ This is a prospective randomized placebo-controlled, doubled-blinded 
study, conducted in Government Rajaji Hospital, Madurai after approval 
of the Institutional Ethics Committee. 
➢ A written informed consent was obtained from each patient after 
explaining the technique before inclusion in this study. 
➢ 60 patients were included in this study. 
➢ The patients were allocated by computer generated randomized number 
into two equal groups of 30 each. 
 
Group 1:  Patients received ultrasound guided supraclavicular brachial plexus 
block using 30 mL of 0.25% bupivacaine + 2ml of distilled water. 
 
Group 2: patients received ultrasound guided supraclavicular brachial plexus 
block 30 mL of 0.25% bupivacaine mixed with 5mg of Verapamil (dilute it as 
2ml).                          
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Inclusion criteria: 
➢ Patients undergoing upper limb surgeries 
➢ ASA 1 and 2 
➢ Age- 18 to 65 years 
➢ Both sexes 
 
Exclusion criteria: 
➢ ASA 3 and 4 
➢ Patient refusal 
➢ Allergic to local anaesthetics 
➢ Coagulation disorder 
➢ Severe Renal, Hepatic and Neurologic disorders 
➢ Infection or inflammation at the site of injection 
➢ Uncontrolled Diabetes mellitus 
➢ Circulatory instability patients 
➢ Patient on verapamil 
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ANAESTHESIA TECHNIQUE 
❖ In the operation theatre, all the patients were secured with 18 G IV line 
and started with IV fluids. 
❖ Pulse rate, Blood Pressure, SpO2, ECG were recorded continuously 
(before and after block). 
❖ Techniques of block were described earlier in this chapter. 
SENSORY BLOCKADE ASSESSMENT: 
➢ Sensory characteristics of the block were assessed using response to 
pinprick to 23-gauge hypodermic needle. 
➢ Patients were pinpricked at every minute to assess for sensory 
blockade. 
➢ To test the radial nerve, the dorsal surface of the thumb was used. 
➢ Palmar surfaces of the index finger for median nerve 
➢ Little finger for ulnar nerve. 
HOLLMEN SCALE: 
1-Normal sensation to pinprick. 
2-Pinprick felt as sharp pointed but weaker with the same area in another limb.  
3-Pinprick recognized as touch with blunt object. 
4-No response to pinprick 
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MOTOR BLOCKADE ASSESSMENT: 
➢ Thumb abduction was evaluated for the radial nerve 
➢ Thumb adduction for the ulnar nerve 
➢ Thumb opposition for the median nerve 
➢ Flexion of elbow for the musculocutaneous nerve 
➢ Modified Lovett rating scale was used for assessing motor block, 
ranging from 6 (usual muscular force) to 0 (complete paralysis) 
LOVETT RATING SCALE: 
0-Complete paralysis 
1-Almost complete paralysis. 
2-Pronounced mobility impairment 
3-Slightly impaired mobility.  
4-Pronounced reduction of muscular force  
5- Slightly reduced muscular force. 
6-Normal muscular force. 
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❖ Surgery started at sensory block scale-3.  
ONSET OF SENSORY BLOCKADE: 
❖ The time of onset of sensory block was defined as the interval between 
the injection of drug to Hollmen sensory scale 2.  
DURATION OF SENSORY BLOCKADE: 
❖ The duration of the sensory block was defined as the time interval 
between the complete sensory block and the return of normal sensation. 
ONSET OF MOTOR BLOCKADE: 
❖ The onset time of motor block was defined as the time between the 
completion of the local anesthetic injection and complete paralysis. 
DURATION OF MOTOR BLOCKADE: 
❖ The duration of motor block was defined as the time interval between the 
complete paralysis and complete recovery of motor function. 
❖ The time to first analgesic use and total dose of analgesics needed were 
recorded during the first 24 h. 
EVALUATION OF PAIN: 
❖ Pain was evaluated using the visual analog scale (VAS) where zero 
represented no pain and 1–3 mild pain, 4–7 moderate pain, and 8– 10-
severe pain.  
 
❖ VAS monitored at 2 h, 4 h, 6 h, 8 h, 10 h, 12 h, 18 h, 24 h after surgery. 
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Fig no 23: VAS score 
❖ If VAS values were >4, it was considered that analgesic action of the 
drugs was terminated and rescue analgesic (iv paracetamol 1 g) given. 
Time for the first dose of rescue analgesia was noted. 
❖ PR, SBP, and DBP were monitored at every 15 min interval up to 2 h 
and then at 4 h, 8 h, 12 h, and at 24 h. 
❖ The level of sedation was assessed by Ramsay sedation scale. 
 
Table no 3: Ramsay sedation score 
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SIDE EFFECTS: 
❖ The possible side-effects such as drowsiness, pruritus, nausea/vomiting, 
Horner’s syndrome, phrenic nerve palsy, pneumothorax, respiratory 
depression, bradycardia, hypotension, and hypoxemia were noted. 
❖ In the circumstance of inadequate or patchy block, the block was 
supplemented with general anesthesia. 
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STATISTICAL ANALYSIS 
❖ Based on the primary aim time needed to first rescue analgesia, with α 
error 0.05 and power of the study (1−β) =80%, sample size was 
calculated to be 28. 
❖ The patient data and block characteristics like the time of onset and 
duration of block were categorized and entered in excel sheet. 
❖ The data were analyzed by chi square test and student unpaired t test 
❖ Results were statistically analyzed by SPSS 20 software. 
❖ P < 0.05 was considered as statistically significant and P < 0.001 as 
statistically highly significant. 
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OBSERVATION 
Table 4 
Age distribution 
AGE (YRS) GROUP 1 GROUP 2 
<30 3 2 
30-40 7 9 
40-50 6 8 
>50 14 11 
TOTAL 30 30 
MEAN 46.9 46.23 
SD 11.24 12.23 
P                   0.8259 (Not Significant) 
 
INFERENCE: Both the groups were comparable in age distribution 
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Table 5 
SEX DISTRIBUTION 
SEX GROUP 1 GROUP 2  
MALE 16 15 
FEMALE 14 15 
TOTAL 30 30 
 
INFERENCE: Both the groups were comparable in sex distribution 
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Table 6 
WEIGHT DISTRIBUTION 
WEIGHT(KGS) GROUP 1 GROUP 2 
<50 1 3 
>50 29 27 
TOTAL 30 30 
MEAN 60.27 61.9 
SD 5.35 7.98 
P 0.3566 NOT SIGNIFICANT 
 
INFERENCE: Both the groups were comparable in weight distribution 
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Table 7 
ASA DISTRIBUTION 
ASA GROUP 1 GROUP 2 
1 13 20 
2 17 10 
TOTAL 30 30 
 
INFERENCE: Both the groups were comparable in ASA distribution 
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TABLE 8 
DURATION OF SURGERY 
DURATION (MINS) GROUP 1 GROUP 2 
<90 3 9 
90-100 10 10 
>100 17 11 
TOTAL 30 30 
MEAN 102.9 98.33 
SD 9.95 11.38 
P 0.1031 NOT SIGNIFICANT 
 
 
INFERENCE: Both the groups were comparable in duration of surgery 
• The mean time for duration of surgery was comparable in both the 
Groups, for Group 1 mean duration were 102.9±9.95 minutes and for 
Group 2 mean duration were 98.33±11.38 minutes. P value of 0.1031 
which is insignificant. 
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Table 9 
ONSET OF SENSORY BLOCKADE 
Onset (mins) Group 1 Group 2 
<10 mins 0 12 
>10 mins 30 18 
TOTAL  30 30 
MEAN  12.73 9.93 
SD 1.43 1.41 
P  <0.0001 HIGHLY SIGNIFICANT 
 
INFERENCE:  
• The onset of sensory blockade in Group 1 was 12.73±1.43 minutes and 
in Group 2 were 9.93±1.41 minutes.  
• The onset was faster in Group 2 compared to Group 1 with P value of 
<0.0001 which is highly significant. 
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ONSET OF SENSORY BLOCKADE 
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Table 10 
ONSET OF MOTOR BLOCKADE 
Onset (mins) Group 1 Group 2 
<15 mins 14 30 
>15 mins 16 0 
TOTAL  30 30 
MEAN  15.9 12.33 
SD 1.53 0.84 
P  <0.0001 HIGHLY SIGNIFICANT 
 
INFERENCE:  
• The onset of motor blockade in Group 1 was 15.90±1.53 minutes and in 
Group 2 were 12.33±0.84 minutes.  
• The onset was faster in Group 2 compared to Group 1 with P value of 
<0.0001 which is highly significant. 
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ONSET OF MOTOR BLOCKADE 
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Table 11 
DURATION OF SENSORY BLOCKADE 
DURATION (mins) Group 1 Group 2 
<300 9 0 
300-350 19 1 
>350 2 29 
TOTAL  30 30 
MEAN  307.83 399.50 
SD 22.77 25.40 
P  <0.0001 HIGHLY SIGNIFICANT 
 
 
INFERENCE:  
• The duration of sensory blockade in Group 1 was 307.83±22.77 minutes 
and in Group 2 were 399.50±25.40 minutes.  
• The duration was longer in Group 2 compared to Group 1 with P value of 
<0.0001 which is highly significant. 
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DURATION OF SENSORY BLOCKADE 
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Table 12 
DURATION OF MOTOR BLOCKADE 
DURATION (mins) Group 1 Group 2 
<300 14 2 
300-350 14 21 
>350 2 7 
TOTAL  30 30 
MEAN  295.8 327.33 
SD 18.43 22.39 
P  <0.0001 HIGHLY SIGNIFICANT 
 
 
INFERENCE:  
• The duration of motor blockade in Group 1 was 295.80±18.43 minutes 
and in Group 2 were 327.33±22.39 minutes.  
• The duration was longer in Group 2 compared to Group 1 with P value of 
<0.0001 which is highly significant. 
 
 
78 
 
 
DURATION OF MOTOR BLOCKADE 
 
 
 
0
50
100
150
200
250
300
350
400
P
A
TI
EN
T 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30
GROUP 1
GROUP 2
0
5
10
15
20
25
GROUP 1 GROUP 2
DURATION OF MOTOR BLOCKADE
<300 300-350 >350
79 
 
Table 13 
DURATION FOR RESCUE ANALGESIA 
DURATION (mins) Group 1 Group 2 
<300 2 2 
300-350 6 2 
>350 22 26 
TOTAL  30 30 
MEAN  375.80 434.06 
SD 37.38 68.20 
P  <0.0001 HIGHLY SIGNIFICANT 
 
INFERENCE:  
• The duration for rescue analgesia in Group 1 was 375.80±37.38 minutes 
and in Group 2 were 434.06±68.20 minutes.  
• The duration for rescue analgesia was longer in Group 2 compared to 
Group with P value of <0.0001 which is highly significant. 
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0
100
200
300
400
500
600
P
A
TI
EN
T 
1 2 3 4 5 6 7 8 9
1
0
1
1
1
2
1
3
1
4
1
5
1
6
1
7
1
8
1
9
2
0
2
1
2
2
2
3
2
4
2
5
2
6
2
7
2
8
2
9
3
0
GROUP 1
GROUP 2
GROUP 1 GROUP 2
2 2
6
2
22
26
DURATION FOR RESCUE ANALGESIA
<300 300-350 >350
81 
 
Table 14 
NUMBER OF RESCUE ANALGESIA DOSES 
DOSES GROUP 1 GROUP 2 
≤ 1 3 16 
2-3 7 5 
>3 20 9 
TOTAL 30 30 
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RESULTS 
➢ Block was successful in all patients and all the enrolled patients 
completed the study. 
➢ The two groups were similar in terms of age, sex, weight, type of surgery 
and duration of surgery and patient satisfaction. 
➢ Pulse rate, systolic blood pressure, diastolic blood pressure and SPO2 
were similar in both the groups. 
ONSET OF SENSORY BLOCKADE: 
➢ Onset of sensory blockade was faster in Group 2 (9.93±1.41 mins) than 
Group 1 (12.73±1.43 mins) with the P value of less than 0.0001 which is 
statistically highly significant. 
ONSET OF MOTOR BLOCKADE: 
➢ Onset of motor blockade was faster in Group 2 (12.33±0.84 mins) than 
Group 1 (15.90±1.53 mins) with the P value of less than 0.0001 which is 
statistically highly significant. 
DURATION OF SENSORY BLOCKADE: 
➢ Duration of sensory blockade was longer in Group 2 (399.50±25.40 
mins) than Group 1 (307.83±22.77 mins) with the P value of less than 
0.0001 which is statistically highly significant. 
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DURATION OF MOTOR BLOCKADE: 
➢ Duration of motor blockade was longer in group 2 (327.33±22.39 mins) 
than Group 1 (295.80±18.43 mins) with the P value of less than 0.0001 
which is statistically highly significant. 
TIME REQUIRED FOR RESCUE ANALGESIA: 
➢ The time required for the first rescue analgesia was longer in Group 2 
(434.06±68.20 mins) than the Group 1 (375.80±37.38 mins) with P value 
of less than 0.0001 which is statistically highly significant. 
 
NUMBER OF RESCUE ANALGESIA NEEDED IN FIRST 24 HRS  
➢ In Group 1 - 3 patients required 1 dose of rescue analgesia, 7 patients 
required 2 or 3 doses of rescue analgesia and 20 patients required more 
than 3 doses of rescue analgesia. 
➢ In Group 2- 16 patients required 1 dose of rescue analgesia, 5 patients 
required 2 or 3 doses of rescue analgesia and 9 patients required more 
than 3 doses of rescue analgesia. 
➢ The difference in both groups were statistically highly significant. 
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➢ There was no failed block or patchy block noted. 
➢ Qualities of the operating condition were excellent in both the groups. 
➢ No untoward events happened during intra operative or post-operative 
period, such as drowsiness, pruritus, nausea/vomiting, Horner’s 
syndrome, phrenic nerve palsy, pneumothorax, respiratory depression, 
bradycardia, hypotension, and hypoxemia. 
➢ Level of sedation was comparable in both the groups. Verapamil has no 
sedative effects. All the patients were awake, cooperative and tranquil 
throughout the intra operative period. 
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DISCUSSION 
❖ Verapamil, a synthetic papaverine derivative is an L type of 
calcium channel blocker. 
❖ Verapamil induces fast sodium channel blocking effects similar to 
local anaesthetics. 
❖ Substance P that stimulates C fibers, can activate the neurokinin I 
receptor and creates slow and long depolarization and aggregate 
calcium flow through calcium channels. NMDA and phospholipase 
C activity that subsequently release calcium through the 
sarcoplasmic reticulum. Increase of intracellular calcium causes 
the increase of dynorphine gene explanation and central sensitivity 
such as wind up phenomenon and augments longer efficacy. So, 
for making a painful message intact the calcium channel is 
essential and any disturbances of calcium ion transmission can 
interfere with pain sensation. 
❖ In our study we have used verapamil with bupivacaine in 
ultrasound guided supraclavicular brachial plexus and concluded 
that verapamil not only reduces the onset time but also increases 
the duration of sensory and motor blockade. 
❖ Number of number analgesia required was low in Group 2 on 
comparing Group 1. 
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ONSET OF SENSORY BLOCKADE: 
➢ Study conducted by Sidharth Sraban Routray, Debasis Mishra, 
Daityari Routray, and Kasturi Nanda using verapamil as adjuvant to 
supraclavicular block concluded that onset of sensory blockade was 
faster than group without adding any additives, mean time was 
10.92±3.84 minutes. 
➢ In our study the mean time for onset was 9.93±1.41 minutes. Other 
studies conducted by Mosaffa et al. and Lalla et al. also yielded 
comparable results. 
 ONSET OF MOTOR BLOCKADE: 
➢ Study conducted by Sidharth Sraban Routray, Debasis Mishra, 
Daityari Routray, and Kasturi Nanda using verapamil as adjuvant to 
supraclavicular block concluded that onset of motor blockade was faster 
than group without adding any additives, mean time was 12.40±3.20 
minutes.  
➢ In our study the mean time was 12.33±0.84 minutes which is 
comparable. Other studies conducted by Mosaffa et al and choe et al 
demonstrated comparable results. 
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DURATION OF SENSORY BLOCKADE: 
➢ In our study the duration of sensory blockade was 399.50±40.0 minutes 
which is comparable with other studies conducted by Mosaffa et al, 
choe et al and sidharth et al. 
DURATION OF MOTOR BLOCKADE: 
➢ In our study the duration of motor blockade was 327.33±22.39 minutes 
which is comparable to studies conducted by Messeha and Eldeen, 
Sidharth et al and Tabaeizavareh et al.  
 
DURATION OF ANALGESIC EFFECTS: 
➢ Studies conducted by Hasegawa and Zacny Miranda et al. and Carta 
et al. and Choe et al suggested that calcium channel blockers combined 
with local anesthetics could increase analgesic effects which is 
comparable to our study.  
 
SIDE EFFECTS: 
➢ Study conducted by Sidharth Sraban Routray, Debasis Mishra, 
Daityari Routray, and Kasturi Nanda using verapamil as adjuvant to 
supraclavicular block concluded that it has no side effects, which is 
comparable to our study. 
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➢ Mosaffa et al. evaluated analgesic effect of 2 doses of verapamil with 
bupivacaine in supraclavicular brachial plexus block. They concluded 
that verapamil (both 2.5 mg and 5 mg) decreased the onset of sensory 
and motor block and increased the duration of analgesia which was 
statistically significant. 
 
➢ Kim et al. opined that verapamil, when added to epidural bupivacaine, 
decreased the postoperative pain through central desensitization. 
 
➢ Lalla et al. in his study concluded that addition of verapamil to 
lignocaine and bupivacaine combine increases the duration of sensory 
blockade which was statistically significant but onset of sensory and 
motor block and duration of motor block was not statistically significant. 
 
➢ Pirec et al. have shown that application of morphine and N type calcium 
channel blockers attenuate pain mediated by A delta and C fiber 
mediated nociception. 
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CONCLUSION 
❖ The addition of verapamil as an adjuvant to bupivacaine for ultrasound 
guided supraclavicular brachial plexus block provides longer duration of 
sensory and motor blockade apart from its rapid onset.  
❖ Hence the required analgesic doses are minimal. 
❖ Being done under ultrasound guidance the risk of complications are 
minimal. 
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PROFORMA 
 
NAME:                                                     I.P.NO:                                 ASA: 
AGE & SEX:                                                                               
WEIGHT: 
DATE & TIME OF ADMISSION:                             DATE& TIME OF 
DISCHARGE: DIAGNOSIS: 
PROCEDURE: 
HISTORY:  
CLINICAL EXAMINATION: PR, BP, SPO2, RS, CVS, P/A and CNS 
BASIC INVESTIGATIONS: 
a) Complete Blood Count 
b) Blood grouping & typing, 
c) BT, CT 
d) Urine routine 
e) Blood urea, RBS, Serum Creatinine, Serum electrolytes 
f) CXR-PA view 
g) ECG, ECHO 
h) USG abdomen 
ANAESTHETIC TECHNIQUE:  
Ultrasound guided supraclavicular brachial plexus block 
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 DOSAGE OF DRUG: 
Group 1:  Patients received ultrasound guided supraclavicular brachial plexus 
block using 30 mL of 0.25% bupivacaine. 
Group 2: patients received ultrasound guided supraclavicular brachial plexus 
block 30 mL of 0.25% bupivacaine mixed with 5mg of Verapamil.                          
EVALUATION OF PR, BP, SPO2 TILL END OF THE PROCEDURE 
CONTINUOUS ECG MONITORING WAS CARRIED OUT THROUGHOUT THE 
PROCEDURE                                                                                                                                           
MONITORING OF VITALS EVERY 15MIN: (ANXIOLYTICS, SEDATIVES, 
ANTIEMETICS AND OTHERS TO BE MENTIONED) 
VITALS PREOP 5MIN 15MIN 30MIN 45MIN 1HR 1HR 
15MIN 
1HR 
30MIN 
2 
HR 
PULSE          
B. P          
SPO2          
SIDE 
EFFECTS 
         
REMARKS          
 
DURATION OF SURGERY: 
ANAESTHESIA RECOVERY TIME: 
IMMEDIATE POSTOPERATIVE PAIN INTENSITY (VAS SCORE): 
                               0 MEANING NO PAIN 
                               10 MEANING EXCRUCIATING PAIN 
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POSTOP PERIOD: MONITORING OF VITALS 
PARAMETER
S 
30MI
N 
1H
R 
2H
R 
4HR
S 
6HR
S 
8HR
S 
10HR
S 
12HR
S 
24HR
S 
PULSE          
B. P          
SPO2          
VAS SCORE          
SIDE 
EFFECTS 
         
REMARKS          
 
(SIDE EFFECTS include drowsiness, pruritus, nausea/vomiting, Horner’s syndrome, 
phrenic nerve palsy, pneumothorax, respiratory depression, bradycardia, 
hypotension, and hypoxemia.)  
 
Parameters  Group 1 
Bupivacaine 0.25 % 
Group 2 
Bupivacaine 0.25% with 
5mg of verapamil 
Onset time of motor 
block 
  
Duration of motor block   
Onset of sensory block   
Duration of sensory 
block 
  
Time to first analgesic 
use 
  
Total dose of analgesics   
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QUESTIONAIRRES USED IN THE STUDY 
 
 
1) H/O Any Known allergy to Local Anaesthetics/ any drugs 
 
2) H/O Previous Neurological deficit 
 
3) H/O Any Bleeding diathesis 
 
4) Any infection/Local sepsis at block site 
 
5) H/O Any Anti-Psychiatric drugs 
 
6) H/O Any systemic illness-Hypertension Diabetes Mellitus, Bronchial Asthma, 
Seizure disorder, Pulmonary Tuberculosis.  
 
7) H/O of smoking, COPD, Exertional dyspnoea, decreased urine output 
(Complaints related to CVS, RS, and RENAL system). 
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GROUP 1 
S.NO NAME AGE SEX WT ASA DURATION OF 
SURGERY 
PRE OP ONSET 
SENSORY 
BLOCK 
ONSET 
MOTOR 
BLOCK 
SENSORY 
BLOCK 
DURATION 
MOTOR 
BLOCK 
DURATION 
PR BP SPO2 
1 RAJA  60 M 58 2 96 85 130/70 98 12 13 270 280 
2 MALAR  42 F 62 2 102 83 120/80 99 13 17 300 290 
3 RAMA  38 F 65 1 105 83 110/80 98 11 15 330 300 
4 UMA  33 F 59 1 100 80 100/70 99 14 18 290 300 
5 ARUN  35 M 49 1 120 75 120/70 97 13 15 280 280 
6 MUTHU  48 M 52 2 108 87 140/70 99 15 17 310 270 
7 SUBRAMANI  49 M 53 2 94 82 120/70 98 10 13 310 300 
8 RAMANI  46 F 58 2 89 78 120/70 98 11 15 300 290 
9 VIGNESH  27 M 56 1 108 86 110/70 99 12 15 290 300 
10 TAMILSELVI 60 F 58 2 112 84 120/80 99 11 16 300 310 
11 KANNAN  62 M 58 2 98 85 110/70 98 14 17 350 280 
12 KARTHIK  33 M 60 1 96 82 120/70 99 15 19 300 310 
13 RAMYA  39 F 62 1 100 83 130/70 98 15 18 360 320 
14 DHIVYA  24 F 64 1 79 88 120/80 99 14 16 320 260 
15 MANIKANDAN  29 M 59 1 96 87 130/70 99 13 15 290 280 
16 ANNAMALAI  48 M 59 2 99 78 120/80 98 12 14 300 275 
17 MANICKAM  52 M 56 2 106 77 110/80 99 14 18 300 310 
18 SIVAGAMI  51 F 64 2 104 82 100/70 97 11 18 310 290 
19 LAKSHMI  53 F 65 2 123 84 120/70 99 12 15 280 300 
20 SANTHOSH KUMAR 56 M 63 1 118 86 140/70 98 12 16 320 295 
21 VEERAIYA  60 M 62 2 116 88 120/70 99 11 16 300 280 
22 RAGU  49 M 60 1 98 78 110/70 98 14 17 310 275 
23 MUTHUSAMY  51 M 70 2 105 80 130/80 98 13 15 340 310 
24 KANAMMAL  54 F 59 2 103 82 120/70 99 12 14 290 300 
25 REVATHI  52 F 72 1 111 84 140/90 99 13 16 315 310 
26 SHANKAR  39 M 68 1 99 86 130/90 99 14 16 365 350 
27 PUNITHA  65 F 63 2 101 88 130/80 98 11 15 310 280 
28 MARIYAMMAL  59 F 65 2 117 89 140/90 99 12 15 290 310 
29 MURUGAN  37 M 59 1 88 78 130/80 99 15 18 315 320 
30 LEELAVATHY  56 F 50 2 96 76 120/80 98 13 15 290 300 
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GROUP 1 
15 MINS 30 MIMS 45 MINS 60 MINS 1 HR 15 MINS 1 HR 30 MINS 1 HR 45 MINS 2 HRS 4 HRS 
PR BP PR BP PR BP PR BP PR BP PR BP PR BP PR BP PR BP 
88 130/70 82 120/80 82 140/70 87 140/70 83 130/70 86 130/90 84 140/90 82 120/70 86 140/70 
87 120/80 84 110/80 84 120/70 82 120/70 88 120/80 88 130/80 86 130/90 78 120/70 88 120/70 
78 130/70 86 100/70 86 110/70 78 120/70 87 130/70 89 140/90 88 130/80 84 140/90 78 110/70 
77 120/80 88 120/70 88 130/80 84 140/90 78 120/80 78 130/80 89 140/90 83 130/70 80 130/80 
82 110/80 78 140/70 78 120/70 83 130/70 77 110/80 76 120/80 87 140/70 88 120/80 89 140/90 
84 100/70 80 120/70 80 140/90 88 120/80 82 100/70 88 120/70 82 120/70 87 130/70 78 130/80 
86 120/70 82 110/70 82 130/90 87 130/70 84 120/70 78 110/70 78 120/70 78 120/80 76 120/80 
88 140/70 84 130/80 84 130/80 78 120/80 86 140/70 80 130/80 84 140/90 76 120/80 88 120/70 
78 120/70 86 120/70 86 140/90 76 120/80 88 120/70 82 120/70 83 130/70 88 120/70 78 110/70 
80 110/70 88 140/90 88 130/80 88 120/70 78 110/70 84 140/90 88 120/80 78 110/70 80 130/80 
82 130/80 89 130/90 89 120/80 78 110/70 80 130/80 86 130/90 87 130/70 80 130/80 82 120/70 
84 120/70 78 130/80 78 120/70 80 130/80 82 120/70 88 130/80 78 120/80 82 120/70 84 140/90 
86 140/90 76 140/90 76 110/70 82 120/70 84 140/90 89 140/90 77 110/80 84 140/90 86 130/90 
88 110/70 88 130/80 88 130/80 84 140/90 86 130/90 87 140/70 82 100/70 86 130/90 88 130/80 
89 130/80 86 120/80 78 120/70 86 130/90 88 130/80 82 120/70 84 120/70 88 130/80 89 140/90 
78 120/70 90 110/80 80 140/90 88 130/80 89 140/90 78 120/70 86 140/70 89 140/90 87 140/70 
76 140/90 88 100/70 82 130/90 89 140/90 78 130/80 84 140/90 88 120/70 87 140/70 88 120/80 
88 130/90 87 120/70 84 130/80 87 140/70 76 120/80 83 130/70 78 110/70 82 120/70 84 140/90 
86 130/80 78 140/70 86 140/90 82 120/70 88 120/70 88 120/80 80 130/80 78 120/70 83 130/70 
90 140/90 77 120/70 88 140/70 78 120/70 78 110/70 87 130/70 82 120/70 84 140/90 88 120/80 
92 130/80 82 110/70 89 120/70 84 140/90 80 130/80 78 120/80 84 140/90 83 130/70 87 130/70 
78 120/80 84 130/80 87 120/70 83 130/70 82 120/70 77 110/80 82 100/70 88 120/80 78 120/80 
76 120/70 86 120/70 82 140/90 88 120/80 84 140/90 82 100/70 82 120/70 84 140/90 77 110/80 
78 140/90 88 140/90 78 140/70 84 140/90 86 130/90 84 120/70 84 140/90 83 130/70 82 100/70 
74 130/90 78 110/70 84 120/70 86 130/90 88 130/80 86 140/70 86 130/90 88 120/80 84 120/70 
96 130/80 80 130/80 86 120/70 88 130/80 89 140/90 88 120/70 88 130/80 87 130/70 86 140/70 
94 140/90 82 120/70 88 130/90 89 140/90 87 140/70 78 110/70 89 140/90 78 120/80 88 120/70 
92 140/70 84 140/90 88 130/80 78 130/80 82 120/70 80 130/80 78 130/80 77 110/80 78 110/70 
80 120/70 86 130/90 92 140/90 76 120/80 78 120/70 82 120/70 76 120/80 82 100/70 80 130/80 
84 120/70 98 140/70 98 130/80 88 120/70 84 140/90 84 140/90 88 120/70 84 120/70 82 120/70 
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GROUP 1 
8 HRS 12 HRS 24 HRS VAS  
LEVEL OF 
SEDATION 
SIDE 
EFFECTS 
FIRST RESCUE 
ANALGESIA PR BP PR BP PR BP 
2 
HRS 
4 
HRS 
6 
HRS 8 HRS 
10 
HRS 
12 
HRS 
18 
HRS 
24 
HRS 
77 110/80 82 120/70 80 130/80 0 0 1 3 4 5 5 6 2 0 380 
82 100/70 78 120/70 82 120/70 0 0 2 4 4 5 5 5 2 0 390 
84 120/70 84 140/90 84 140/90 0 0 1 3 4 5 5 6 2 0 300 
86 140/70 83 130/70 86 130/90 0 0 2 3 4 5 5 5 2 0 400 
88 120/70 88 120/80 88 130/80 0 0 2 3 5 6 6 6 2 0 380 
78 110/70 87 130/70 89 140/90 0 0 2 3 4 5 4 5 2 0 350 
80 130/80 78 120/80 78 130/80 0 0 2 3 5 5 4 6 2 0 360 
82 120/70 76 120/80 76 120/80 0 0 2 3 4 6 4 5 1 0 380 
84 140/90 88 120/70 88 120/70 0 1 3 3 5 5 5 6 2 0 360 
86 130/90 78 110/70 78 110/70 0 1 2 4 4 4 4 6 2 0 350 
88 130/80 80 130/80 80 130/80 0 0 2 4 5 5 4 5 2 0 410 
89 140/90 82 120/70 82 120/70 0 0 2 4 4 5 5 6 2 0 400 
78 130/80 84 140/90 84 140/90 0 0 1 4 4 5 5 6 2 0 420 
76 120/80 86 130/90 86 130/90 0 2 3 4 4 5 6 5 1 0 400 
88 120/70 88 130/80 88 120/80 0 0 3 3 5 5 5 6 2 0 410 
78 110/70 89 140/90 87 130/70 0 0 2 3 5 5 5 6 1 0 360 
80 130/80 87 140/70 78 120/80 0 0 2 3 5 5 5 6 2 0 380 
82 120/70 82 120/70 77 110/80 0 1 2 3 5 5 5 7 2 0 390 
84 140/90 84 140/90 82 100/70 0 0 2 3 4 5 6 6 1 0 450 
86 130/90 86 130/90 84 120/70 0 0 1 3 4 4 5 7 2 0 460 
88 120/80 88 130/80 86 140/70 0 2 3 2 4 5 6 6 2 0 350 
87 130/70 89 140/90 88 120/70 0 1 2 3 5 6 6 7 2 0 360 
78 120/80 78 130/80 78 110/70 0 0 2 3 5 5 6 7 2 0 320 
77 110/80 76 120/80 80 130/80 0 1 2 3 5 6 6 6 1 0 330 
82 100/70 88 120/70 78 120/70 0 1 1 3 5 5 6 7 2 0 300 
84 120/70 88 130/80 73 120/80 0 1 2 3 6 5 4 6 2 0 400 
86 140/70 89 140/90 71 130/70 0 2 3 3 6 5 5 6 2 0 360 
88 120/70 87 140/70 75 120/80 0 1 2 2 5 5 5 6 1 0 380 
78 110/70 88 120/80 74 110/80 0 2 3 4 6 5 6 6 2 0 390 
80 130/80 84 140/90 76 100/70 0 2 3 4 6 5 5 6 2 0 350 
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GROUP 2 
S.NO NAME AGE SEX WT ASA 
DURATION 
OF 
SURGERY 
PRE OP ONSET 
SENSORY 
BLOCK 
ONSET 
MOTOR 
BLOCK 
SENSORY 
BLOCK 
DURATION 
MOTOR 
BLOCK 
DURATION PR BP SPO2 
1 SUMITHRA 24 F 65 1 110 78 110/70 99 10 13 380 320 
2 NAGARATHINAM 49 M 59 2 98 80 130/80 100 9 13 420 330 
3 RANJANI 34 F 63 1 89 74 120/80 98 9 14 390 340 
4 KRISHNAMOORTRHY 63 M 60 2 102 98 150/90 99 11 12 430 360 
5 SUGANTHI 35 F 48 1 106 90 100/60 99 10 13 425 320 
6 PRABHADEVI 46 F 52 1 100 92 130/80 100 8 12 410 310 
7 MANGALESWARI 39 F 70 1 95 85 140/80 100 8 11 455 300 
8 PANDI 65 M 63 2 90 86 150/90 100 9 12 470 350 
9 JOTHILAKSHMI 63 F 58 2 75 82 120/90 98 10 13 395 360 
10 MEENAKSHI 60 F 60 2 80 75 140/90 99 9 12 405 330 
11 NAJIMA 58 F 59 1 95 79 130/90 98 9 12 410 360 
12 PERUMAL 49 M 62 1 90 68 120/80 99 9 11 420 340 
13 MUNIYANDI 62 M 45 1 110 80 140/80 99 7 12 390 350 
14 PUSHPAM 55 F 63 1 110 95 130/70 99 10 13 380 360 
15 PARABADEVI 49 F 73 1 100 92 120/80 97 10 12 370 370 
16 VASUDEVAN 49 M 60 1 120 90 110/80 98 11 14 380 320 
17 KALYANI 38 F 55 1 110 86 110/80 99 12 13 400 330 
18 BALUISAMY 59 M 49 2 100 83 130/90 98 11 12 390 310 
19 RAMALINGAM 46 M 63 1 105 78 120/70 100 10 13 385 330 
20 AARTHY 23 F 62 1 110 74 100/70 100 12 12 360 340 
21 THIYAGARAJAN 60 M 56 2 95 73 130/90 100 13 11 350 325 
22 SUMATHI 33 F 70 1 90 72 110/70 98 12 12 400 300 
23 RAJA 40 M 69 1 85 89 120/70 99 11 13 390 290 
24 SUDHAKAR 34 M 74 2 90 88 130/80 97 12 12 380 290 
25 MANIMARAN 36 M 68 1 80 79 100/70 98 10 12 420 300 
26 JEYANTHI 45 F 52 1 90 76 140/90 99 10 11 400 300 
27 SELVARAJ 51 M 70 2 95 100 160/100 99 9 12 410 310 
28 RAMACHANDRAN 56 M 69 2 100 106 150/90 100 8 12 390 325 
29 SIVAGAMI 36 F 62 1 110 78 120/70 100 9 12 400 320 
30 
BASKAR 30 M 78 1 120 98 130/80 98 
10 14 380 330 
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GROUP 2 
15 MINS 30 MIMS 45 MINS 60 MINS 1 HR 15 MINS 
1 HR 30 
MINS 1 HR 45 MINS 2 HRS 4 HRS 
PR BP PR BP PR BP PR BP PR BP PR BP PR BP PR BP PR BP 
79 130/70 92 110/70 78 100/70 86 100/60 78 120/70 78 120/80 82 120/70 78 140/90 95 130/80 
68 120/80 90 120/70 98 140/90 83 130/80 98 100/70 86 140/80 84 100/70 90 110/70 89 100/70 
80 110/80 86 130/80 90 110/70 78 140/80 90 130/90 78 130/70 78 130/90 85 130/80 75 140/90 
95 110/80 83 100/70 80 130/80 74 150/90 80 110/70 85 120/80 90 110/70 87 120/80 74 110/70 
92 130/90 78 140/90 78 120/80 73 120/90 78 120/70 86 110/80 85 120/70 95 150/90 70 130/80 
90 120/70 74 110/70 86 150/90 72 140/90 86 130/80 68 110/80 87 130/80 89 100/60 68 140/90 
86 100/70 73 130/80 78 100/60 89 130/90 78 100/70 80 130/90 95 100/70 75 130/80 96 110/70 
83 130/90 72 120/80 85 130/80 88 120/80 85 140/90 95 120/70 89 140/90 74 140/80 95 120/70 
78 110/70 89 150/90 86 140/80 79 140/80 86 160/100 92 100/70 75 110/70 70 150/90 78 130/80 
74 120/70 88 100/60 68 150/90 76 130/70 90 150/90 90 130/90 74 120/70 68 120/90 80 100/70 
73 130/80 79 130/80 80 120/90 100 120/80 78 120/70 86 110/70 70 130/80 96 140/90 84 140/90 
72 100/70 76 140/80 95 140/90 106 110/80 80 130/80 83 120/70 68 100/70 95 130/90 86 110/70 
89 140/90 100 150/90 92 130/90 78 110/80 80 120/80 68 130/80 96 140/90 78 120/80 89 130/80 
88 110/70 106 120/90 90 120/80 98 130/90 95 150/90 80 100/70 95 110/70 80 110/80 89 120/80 
79 130/80 78 140/90 86 110/80 90 120/70 92 100/60 95 140/90 78 130/80 84 110/80 95 150/90 
76 120/80 98 130/90 83 110/80 80 100/70 90 130/80 92 110/70 80 120/80 86 130/90 96 100/60 
100 150/90 90 120/80 68 130/90 78 130/90 86 140/80 90 120/70 84 150/90 89 120/70 87 110/70 
106 100/60 80 110/80 80 120/70 86 110/70 83 150/90 86 130/80 86 100/60 89 100/70 89 130/80 
78 130/80 78 110/80 95 100/70 78 120/70 78 120/90 83 100/70 89 110/70 95 130/90 79 120/80 
98 140/80 86 130/90 92 130/90 85 130/80 74 140/90 78 140/90 93 130/80 96 130/90 82 110/70 
90 150/90 78 120/70 90 130/90 86 100/70 73 130/90 74 110/70 91 120/80 87 130/70 68 130/80 
80 120/90 85 100/70 86 120/80 90 140/90 72 120/80 73 130/80 100 150/90 89 120/80 80 120/80 
78 140/90 86 130/90 83 130/80 78 130/70 89 140/80 72 120/80 102 100/60 79 110/80 95 150/90 
86 130/90 68 110/70 78 100/70 80 120/80 88 130/70 80 150/90 89 130/80 82 110/80 92 100/60 
78 120/80 80 120/70 74 140/90 90 110/80 79 120/80 95 100/60 95 140/80 68 130/90 90 130/80 
85 130/80 95 130/80 73 110/70 80 110/80 86 110/80 92 130/80 96 150/90 80 120/70 84 140/80 
86 100/70 92 100/70 72 120/70 78 130/90 83 110/80 90 140/80 87 120/90 95 100/70 86 150/90 
90 140/90 90 140/90 89 100/60 86 120/70 78 130/90 86 150/90 89 140/90 92 130/90 89 120/90 
78 110/70 86 110/70 88 130/80 78 100/70 74 120/70 83 120/90 79 120/70 90 110/70 89 140/90 
80 120/70 83 130/80 79 110/70 85 130/90 73 100/70 68 130/80 82 110/80 88 120/70 95 130/90 
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GROUP 2 
8 HRS 12 HRS 24 HRS VAS  
LEVEL OF 
SEDATION 
SIDE 
EFFECTS 
FIRST RESCUE 
ANALGESIA PR BP PR BP PR BP 
2 
HRS 
4 
HRS 
6 
HRS 
8 
HRS 
10 
HRS 
12 
HRS 
18 
HRS 
24 
HRS 
80 120/80 87 100/70 96 110/80 0 0 0 2 2 3 3 4 2 0 450 
74 120/90 95 140/90 87 130/90 0 0 0 2 2 3 4 5 2 0 500 
98 140/90 89 110/70 89 100/60 0 0 1 2 3 3 3 4 2 0 480 
90 130/90 75 120/70 79 110/70 0 0 0 2 3 3 3 5 2 0 300 
92 120/80 74 130/80 82 130/80 0 0 0 3 3 4 3 5 1 0 390 
85 110/80 70 100/70 68 120/80 0 0 0 2 3 3 3 4 2 0 300 
86 110/80 68 140/90 80 150/90 0 0 2 2 3 3 3 4 2 0 450 
82 130/90 96 110/70 95 100/60 0 0 1 3 3 3 3 4 2 0 470 
75 120/70 95 130/80 92 130/80 0 0 2 2 3 4 4 4 2 0 480 
79 100/70 78 120/80 90 140/80 0 0 2 3 3 3 4 4 1 0 520 
68 130/90 80 150/90 84 130/80 0 0 3 3 3 4 3 5 2 0 500 
80 130/90 84 100/60 86 140/80 0 0 2 2 3 3 4 4 2 0 530 
95 130/70 86 110/70 89 150/90 0 0 2 3 3 3 3 5 2 0 450 
92 120/80 89 130/80 89 120/90 0 0 2 2 2 4 3 4 2 0 360 
90 110/80 98 120/80 95 140/90 0 0 2 3 3 3 3 5 2 0 350 
86 110/70 90 150/90 80 130/90 0 0 2 3 3 4 3 4 2 0 390 
83 120/70 92 100/60 84 120/80 0 0 2 3 2 3 3 4 1 0 320 
78 130/80 85 130/80 86 100/60 0 0 0 2 2 3 3 5 2 0 330 
74 100/70 86 140/80 89 130/80 0 0 2 2 3 3 3 5 2 0 490 
73 140/90 82 130/80 98 140/80 0 0 1 2 3 4 4 4 2 0 460 
72 110/70 75 140/80 90 150/90 0 0 2 2 3 3 3 4 2 0 480 
89 120/70 79 150/90 92 120/90 0 0 2 3 3 3 4 5 1 0 510 
88 130/80 68 120/90 85 140/90 0 0 3 3 3 3 4 4 1 0 500 
79 100/70 78 140/90 86 130/90 0 0 2 3 3 4 4 4 2 0 450 
70 140/90 74 130/90 82 120/80 0 0 2 3 3 3 3 4 2 0 490 
68 110/70 73 120/80 75 110/80 0 0 0 1 2 3 4 4 2 0 460 
96 130/80 72 140/80 79 110/80 0 0 2 2 3 4 3 5 2 0 390 
95 120/80 89 130/70 89 130/90 0 0 3 3 2 3 3 5 1 0 380 
78 120/70 88 120/80 89 120/70 0 0 2 3 3 3 3 4 1 0 390 
80 110/80 79 110/80 88 130/80 0 0 0 2 2 3 3 5 2 0 450 
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